Background

Mr. S. Edward Torres, also known as Ed has been the Co-Founder and Managing Director since 2009 at Lilly Ventures Management Company, LLC. He oversees Lilly Venture's operations. He joined Eli Lilly and Company in 1989. He was the Founding Chief Financial Officer at Lilly Argentina. He was a part of the Management team that built a successful and profitable business there. He serves as an Executive Director of Esanex, Inc. He serves as a Board Observer of Xenoport, Inc. ... Mr. Torres has been a Director at Cylene Pharmaceuticals Inc since January 23, 2007; Receptos, Inc, since November 2009; and GlobeImmune, Inc since November 2010. He has been a Director of Viamet Pharmaceuticals, Inc. and Viamet Pharmaceuticals Holdings, LLC since December 2011 and various non-profit institutions. He serves as a Director of GlobeImmune. He served as Director of Coherus Biosciences, Inc., until June 2014. He served as a Director of Fluidigm Corporation, Cabrellis Pharmaceuticals Corp., Trinity Biosystems, Inc, Coserics, LLC, Conforma Therapeutics, and Serenex, Inc. He has a diverse set of experiences throughout the domestic and international pharmaceutical businesses including operational finance, planning, mergers and acquisitions, business development, and global marketing roles. He has over 25 years of experience in the pharmaceutical and venture capital businesses. Mr. Torres holds an M.B.A. degree from University of Michigan Business School, where he was a Consortium Fellow and a B.A. from Creighton University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.